Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Redwoods Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
Redwoods Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit
-
Redwoods Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering on Nasdaq
-
IPO for SPAC Redwoods Acquisition (RWOD) Opens at $10.05
-
Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
-
UPDATE: Chardan Capital Markets Starts Silence Therapeutics (SLN) at Buy
-
AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results
-
Form 10-K Chardan NexTech Acquisit For: Dec 31
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
-
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
-
Medallion Resources Announces Board Changes
-
U.S. step to delist Chinese ADRs worsens investment, listing outlook
-
Chinese startups' SPAC listings gather pace as tougher offshore IPO rules loom
-
Insignia Systems, Inc. Announces Fourth Quarter And Full Year 2021 Financial Results
-
Arbutus Biopharma (ABUS) PT Raised to $6 at Chardan Capital Markets
-
Valens Semiconductor to Participate in Upcoming March Investor Events
-
CleanTech Acquisition Corp. and Nauticus Robotics to Present at the 34th Annual ROTH Conference
-
CleanTech Acquisition Corp. and Nauticus Robotics to Present at the 34th Annual ROTH Conference
-
Intellia Therapeutics (NTLA) PT Lowered to $172 at Chardan Capital Markets
-
Metagenomi to Present at the Chardan 2022 Metagenomics and Microbiome Medicines Summit
-
Iovanace Biotherapeutics (IOVA) PT Lowered to $45 at Chardan Capital Markets
-
Form SC 13G Chardan NexTech Acquisit Filed by: Chardan NexTech Investments 2 LLC
-
BiomX Presenting at Three Upcoming Investor Conferences
-
Synlogic To Present at Upcoming Investor and Industry Conferences
-
Vedanta Biosciences to Present at Chardan’s 2022 Metagenomics and Microbiome Medicines Summit
-
Persephone Biosciences to Present at Chardan’s 4th Annual Metagenomics and Microbiome Medicines Summit
-
Finch Therapeutics to Participate in the Chardan Metagenomics and Microbiome Medicines Summit
-
4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
-
Finch Therapeutics to Participate in the Chardan Metagenomics and Microbiome Medicines Summit
-
Broad Capital Acquisition Corp Announces Separate Trading of its Common Stock and Rights, Commencing February 23, 2022
-
Seres Therapeutics to Present at Chardan Metagenomics and Microbiome Medicines Summit
-
Armata Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
IPO for A SPAC I Acquisition Corp. (ASCA) Opens at $10.03
-
Nauticus Robotics Announces U.S. Defense Innovation Unit Award for Autonomous Subsea Command and Control Software (CLAQ)
-
Nauticus Robotics Announces U.S. Defense Innovation Unit Award for Autonomous Subsea Command and Control Software
-
Ameristar Casinos, Inc. (ASCA) Prices 6M Unit IPO at $10/unit
-
A SPAC I Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
-
Form SC 13G Chardan NexTech Acquisit Filed by: HGC Investment Management Inc.
-
ThinkMarkets secures US$40 million Growth Capital Funding Package from Leading Institutional Investors
-
Form SC 13G Chardan NexTech Acquisit Filed by: Weiss Asset Management LP
-
Form SC 13G Chardan NexTech Acquisit Filed by: Polar Asset Management Partners Inc.
-
Form SC 13G/A Chardan NexTech Acquisit Filed by: MMCAP International Inc. SPC
-
Wag Labs to Go Public Via Merger with CHW Acquisition Corporation (CHWA)
-
Wag Labs, Inc. to Become Listed through $350 million Business Combination with CHW Acquisition Corporation
-
LogicBio Therapeutics (LOGC) PT Lowered to $6 at Chardan Capital Markets, Following Clinical Business Update
-
CleanTech Acquisition Corp. Files Registration Statement on Form S-4 as Part of Proposed Business Combination with Nauticus Robotics, Inc. a Developer of AI Software to Power its Ocean-Going Robot Fle
-
CleanTech Acquisition Corp. Files Registration Statement on Form S-4 as Part of Proposed Business Combination with Nauticus Robotics, Inc. a Developer of AI Software to Power its Ocean-Going Robot Fle

